Chengshu Capital
Overview
Chengshu Capital is a private equity firm founded in 2010 that focuses on growth-stage investments in the life sciences, consumer healthcare, and medical devices sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ningbo HicRen Biotechnology Co., Ltd. | Jun 2025 | Strategic | Co-investor |
| Shanghai Weimu Medical Technology Co., Ltd. | Dec 2023 | Series A | Co-investor |
| Taizhou Baiying Biotechnology | Sep 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Chengshu Capital based?
Chengshu Capital is headquartered in Shanghai, China.
When was Chengshu Capital founded?
Chengshu Capital was founded in 2010.
How many portfolio companies does Chengshu Capital have?
Chengshu Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Chengshu Capital's portfolio?
Recent investments visible on Caplight include Ningbo HicRen Biotechnology Co., Ltd., Shanghai Weimu Medical Technology Co., Ltd., Taizhou Baiying Biotechnology.
What was Chengshu Capital's most recent investment?
Chengshu Capital's most recent investment on Caplight was in Ningbo HicRen Biotechnology Co., Ltd. in 2025.
What sectors does Chengshu Capital focus on?
Chengshu Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Chengshu Capital focus on?
Stage focus information for Chengshu Capital is not publicly available.